Sort by 'likes'
Mastectomies and BRCA – Are we over preparing?
According to the National Cancer Institute, a women's risk of developing breast cancer or ovarian cancer greatly increases if she inherits the mutation in the BRCA1 gene or the BRCA2 gene. In May 2014, actress Angelina Jolie underwent a preventive…
Discussing Multiple Myeloma with Dr. Lalit Kumar from AIIMS, INDIA
Dr. Lalit Kumar, MD, DM, a Fulbright scholar, Professor and head of Medical Oncology at the All India Institute of Medical Sciences (AIIMS) , New Delhi (India) educates our audience about multiple myeloma.
Approaches to Prevent Breast Cancer Recurrence
Breast cancer recurrence, often occurring years after initial treatment, poses a significant challenge to patients and caregivers. Dormant tumor cells, also known as 'sleeper cells,' persist in the body after treatment and may reactivate to cause recurrence. Predicting recurrence remains…
Risk Stratfiied Treatment and Active Surveillance in Prostate Cancer
Should you opt for active surveillance when diagnosed with prostate cancer or Does your PSA test warrant more aggressive therapy instead? Tune in to hear Dr.Matthew Cooperberg’s views on the controversial PSA testing and hear him talk about treatments based…
Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment
Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component…